XBI vs. ET
XBI (SPDR S&P Biotech ETF) is Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index, while ET (Energy Transfer LP) is a stock. Over the past 10 years, XBI returned 9.98%/yr vs 12.78%/yr for ET. At a 0.29 correlation, their price movements are largely independent.
Performance
XBI vs. ET - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XBI achieves a 11.87% return, which is significantly lower than ET's 18.84% return. Over the past 10 years, XBI has underperformed ET with an annualized return of 9.98%, while ET has yielded a comparatively higher 12.78% annualized return.
XBI
- 1D
- 1.95%
- 1M
- 4.37%
- YTD
- 11.87%
- 6M
- 11.41%
- 1Y
- 63.76%
- 3Y*
- 16.08%
- 5Y*
- 0.52%
- 10Y*
- 9.98%
ET
- 1D
- -0.84%
- 1M
- -6.15%
- YTD
- 18.84%
- 6M
- 18.77%
- 1Y
- 11.20%
- 3Y*
- 23.21%
- 5Y*
- 19.85%
- 10Y*
- 12.78%
XBI vs. ET - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBI SPDR S&P Biotech ETF | 11.87% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
ET Energy Transfer LP | 18.84% | -9.37% | 53.87% | 27.87% | 55.74% | 42.96% | -44.92% | 5.88% | -17.74% | -4.66% |
Correlation
The correlation between XBI and ET is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Feb 6, 2006 | 0.29 |
The correlation between XBI and ET shifts across timeframes, from -0.03 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBI vs. ET — Risk / Return Rank
XBI
ET
XBI vs. ET - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and Energy Transfer LP (ET). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XBI | ET | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.75 | ||
| Sortino ratioReturn per unit of downside risk | +2.15 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.13 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 6.59 | 1.28 | +5.31 |
| Martin ratioReturn relative to average drawdown | 19.47 | 2.91 | +16.56 |
Loading charts...
Drawdowns
XBI vs. ET - Drawdown Comparison
The maximum XBI drawdown since its inception was -63.89%, smaller than the maximum ET drawdown of -87.81%. Use the drawdown chart below to compare losses from any high point for XBI and ET.
Loading charts...
Drawdown Indicators
| XBI | ET | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.89% | -87.81% | +23.92% |
Max Drawdown (1Y)Largest decline over 1 year | -9.72% | -8.79% | -0.93% |
Max Drawdown (3Y)Largest decline over 3 years | -32.99% | -24.56% | -8.43% |
Max Drawdown (5Y)Largest decline over 5 years | -54.71% | -24.56% | -30.15% |
Max Drawdown (10Y)Largest decline over 10 years | -63.89% | -72.82% | +8.93% |
Current DrawdownCurrent decline from peak | -21.16% | -7.26% | -13.90% |
Average DrawdownAverage peak-to-trough decline | -20.93% | -25.72% | +4.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.29% | 4.24% | -0.95% |
Volatility
XBI vs. ET - Volatility Comparison
SPDR S&P Biotech ETF (XBI) has a higher volatility of 10.55% compared to Energy Transfer LP (ET) at 4.85%. This indicates that XBI's price experiences larger fluctuations and is considered to be riskier than ET based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XBI | ET | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.55% | 4.85% | +5.70% |
Volatility (6M)Calculated over the trailing 6-month period | 20.83% | 12.07% | +8.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.18% | 16.13% | +10.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.22% | 24.87% | +7.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.03% | 35.00% | -2.97% |
Dividends
XBI vs. ET - Dividend Comparison
XBI's dividend yield for the trailing twelve months is around 0.32%, less than ET's 7.06% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ET Energy Transfer LP | 7.06% | 7.97% | 6.51% | 8.95% | 7.33% | 7.41% | 17.27% | 9.51% | 9.24% | 6.66% | 5.90% | 7.42% |
XBI SPDR S&P Biotech ETF | 0.32% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
XBI and ET have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (10.55%) compared to ET (4.85%). In terms of maximum drawdown, XBI dropped -63.89% vs ET's -87.81%.
XBI currently has the higher Sharpe Ratio (2.45 vs 0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XBI and ET
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer